New Research Reveals Novel Method to Starve Prostate Cancer Tumors
/0 Comments/in Preclinical Research/by MaxGenomenon Unveils Groundbreaking Genomic Knowledgebase Powered by AI
/0 Comments/in Artificial Intelligence/by MaxDinuclear Platinum(II) Complexes: A Promising New Chemotherapy to Treating Prostate Cancer
/0 Comments/in Chemotherapy, Preclinical Research/by MaxNewsletter 5
/0 Comments/in Newsletter/by MaxLAST WEEK TODAY! A summary of what was published on ProstateWarriors.com during the past week Here I am with the fifth newsletter from the site. I hope I will be like Santa Prostate and bring you some exciting discovery by Christmas! We also have a podcast if you prefer to listen to the newsletter, you can find it […]
Hijacking the Brakes: Scientists Uncover Prostate Cancer’s Growth Secret
/0 Comments/in CRISPR, Preclinical Research/by MaxDietary Intervention Shows Promise in Slowing Prostate Cancer Progression
/0 Comments/in Clinical Trial, Localized/by MaxInvikafusp Alfa: New Hope for Advanced, Anti-PD-1 Resistant Cancers Phase 1 and 2 Trial
/0 Comments/in Clinical Trial, Metastatic, Phase 1, Phase 2/by MaxA New Hope for Hard-to-Treat Cancers: a New TACC3 Inhibitor
/0 Comments/in Clinical Trial, Not PCa related/by MaxTiny Robots Revolutionize Targeted Drug Delivery: Caltech’s Microscopic Marvels
/0 Comments/in Delivery, Preclinical Research/by MaxProject Navigator
Let's try to finance it!
A new, user friendly way, to get information about current clinical trials available to prostate cancer patients.
Tags
225Ac abiraterone acetate ADC AI ai in healthcare alphafold antibody-drug conjugate apalutamide ATM B7-H3 bispecific antibody bone metastases bone metastasis BRCA BRCA2 cancer immunotherapy CAR-T clinical trial clinical trials crispr darolutamide drug repurposing drug resistance enzalutamide HRR immunotherapy mcrpc metastatic castration-resistant prostate cancer metastatic hormone-sensitive prostate cancer mHSPC mRNA NEPC neuroendocrine prostate cancer olaparib oncolytic virus PARP inhibitor Pluvicto prostate cancer protac PSMA radioligand therapy radiopharmaceuticals real-world data STAMPEDE trial theranostics
Latest Posts
- Newsletter 37/2025 September 14, 2025
- OST-504: A Novel Immunotherapy Targeting Prostate Cancer September 13, 2025
- Memantine Shows Promise Against Advanced Prostate Cancer September 11, 2025
- Pasritamig in Late-Line Prostate Cancer: From Early Findings to the KLK2-comPAS Trial September 11, 2025